PMDA — authorised 18 June 2019
- Marketing authorisation holder: ALNYLAM JAPAN K.K.
- Status: approved
🇯🇵 Onpattro in Japan
PMDA authorised Onpattro on 18 June 2019
Marketing authorisation
Onpattro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Onpattro approved in Japan?
Yes. PMDA authorised it on 18 June 2019.
Who is the marketing authorisation holder for Onpattro in Japan?
ALNYLAM JAPAN K.K. holds the Japanese marketing authorisation.